Terns Pharmaceuticals (TERN) Insider Trading & Ownership → Free report reveals “two-baggers” for 2024 (From TradingTips) (Ad) Free TERN Stock Alerts $5.90 -0.24 (-3.91%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Terns Pharmaceuticals (NASDAQ:TERN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.12 M Get TERN Insider Trade Alerts Want to know when executives and insiders are buying or selling Terns Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TERN Insider Buying and Selling by Quarter Ad DTIDid you know you can now trade Bitcoin in your regular brokerage account?You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!>> Tap here to sign up and join them for the imminent workshop Terns Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20 4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83 (Data available from 1/1/2013 forward) TERN Insider Trading Activity - Frequently Asked Questions Who is on Terns Pharmaceuticals's Insider Roster? The list of insiders at Terns Pharmaceuticals includes Biosciences Fund V L.P. Lav, Hongbo Lu, Orbimed Advisors Llc, and Vivo Opportunity, Llc. Learn more on insiders at TERN. What percentage of Terns Pharmaceuticals stock is owned by insiders? 17.40% of Terns Pharmaceuticals stock is owned by insiders. Learn more on TERN's insider holdings. Which Terns Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TERN shares in the last 24 months: Hongbo Lu ($3,630,000.00), Orbimed Advisors Llc ($999,999.75), and Vivo Opportunity, Llc ($11,010,239.40). How much insider buying is happening at Terns Pharmaceuticals? Insiders have purchased a total of 4,120,790 TERN shares in the last 24 months for a total of $15,640,239.15 bought. Which Terns Pharmaceuticals insiders have been selling company stock? The following insiders have sold TERN shares in the last 24 months: Biosciences Fund V L.P. Lav ($8,250,000.00), and Vivo Opportunity, Llc ($2,122,017.03). How much insider selling is happening at Terns Pharmaceuticals? Insiders have sold a total of 1,819,183 Terns Pharmaceuticals shares in the last 24 months for a total of $10,372,017.03 sold. More Insider Trading Tools from MarketBeat Related Companies: RANI Insider Ownership ERAS Insider Ownership NATR Insider Ownership HROW Insider Ownership ADCT Insider Ownership AMRN Insider Ownership PGEN Insider Ownership ATAI Insider Ownership ANRO Insider Ownership SBTX Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:TERN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.